Maria Secrier
Maria Secrier
Lecturer in Computational Biology, UCL Genetics Institute, University College London
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Using graph theory to analyze biological networks
GA Pavlopoulos, M Secrier, CN Moschopoulos, TG Soldatos, S Kossida, ...
BioData mining 4 (1), 1-27, 2011
5622011
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis
JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...
Nature genetics 46 (8), 837-843, 2014
2802014
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ...
Nature genetics 48 (10), 1131-1141, 2016
2082016
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
CS Ross-Innes, J Becq, A Warren, RK Cheetham, H Northen, ...
Nature genetics 47 (9), 1038-1046, 2015
1942015
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
X Li, HE Francies, M Secrier, J Perner, A Miremadi, N Galeano-Dalmau, ...
Nature communications 9 (1), 1-13, 2018
792018
The ABC of reverse engineering biological signalling systems
M Secrier, T Toni, MPH Stumpf
Molecular BioSystems 5 (12), 1925-1935, 2009
542009
Arena3D: visualizing time-driven phenotypic differences in biological systems
M Secrier, GA Pavlopoulos, J Aerts, R Schneider
BMC bioinformatics 13 (1), 1-11, 2012
482012
Visualizing time-related data in biology, a review
M Secrier, R Schneider
Briefings in bioinformatics 15 (5), 771-782, 2014
432014
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
F Noble, MA Lloyd, R Turkington, E Griffiths, M O'Donovan, JR O'Neill, ...
The British journal of surgery 104 (13), 1816, 2017
402017
Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts
T Sawas, S Killcoyne, PG Iyer, KK Wang, TC Smyrk, JB Kisiel, Y Qin, ...
Gastroenterology 155 (6), 1720-1728. e4, 2018
362018
How neurons migrate: a dynamic in-silico model of neuronal migration in the developing cortex
Y Setty, CC Chen, M Secrier, N Skoblov, D Kalamatianos, S Emmott
BMC systems biology 5 (1), 1-13, 2011
272011
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy
FR Talukdar, M di Pietro, M Secrier, M Moehler, K Goepfert, SSC Lima, ...
Annals of the New York Academy of Sciences 1434 (1), 342-359, 2018
252018
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
N De Silva, L Schulz, A Paterson, W Qain, M Secrier, E Godfrey, H Cheow, ...
British journal of cancer 113 (9), 1305-1312, 2015
252015
Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with …
M Secrier, X Li, N de Silva, MD Eldridge, G Contino, J Bornschein, ...
Nat Genet 48 (10), 1131-41, 2016
222016
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
E Garcia, A Hayden, C Birts, E Britton, A Cowie, K Pickard, M Mellone, ...
Scientific reports 6 (1), 1-17, 2016
212016
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
A Noorani, X Li, M Goddard, J Crawte, LB Alexandrov, M Secrier, ...
Nature genetics 52 (1), 74-83, 2020
182020
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre-and post-chemotherapy
A Noorani, J Bornschein, AG Lynch, M Secrier, A Achilleos, M Eldridge, ...
Genome research 27 (6), 902-912, 2017
162017
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
RC Turkington, LA Knight, JK Blayney, M Secrier, R Douglas, EE Parkes, ...
Gut 68 (11), 1918-1927, 2019
142019
Whole-genome sequencing of nine esophageal adenocarcinoma cell lines
G Contino, MD Eldridge, M Secrier, L Bower, RF Elliott, J Weaver, ...
F1000Research 5, 2016
132016
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
M Prudencio, J Humphrey, S Pickles, AL Brown, SE Hill, JM Kachergus, ...
The Journal of Clinical Investigation 130 (11), 6080-6092, 2020
82020
The system can't perform the operation now. Try again later.
Articles 1–20